Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PRCP | P42785 | 2/20 | 0.38 |
| ▸ | REN | P00797 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.38 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.37 |
| ▸ | CAPN9 | O14815 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CTSC | P53634 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30099495 | 0.95 | MEN1 (0.41) | MEN1KMT2ATERTDPP7ALDH1A1 | |
| SCHEMBL30099556 | 0.92 | TERT (0.42) | MEN1KMT2ATERTDPP7ALDH1A1 | |
| SCHEMBL30487458 | 0.91 | TERT (0.51) | MEN1KMT2ATERTDPP7ALDH1A1 | |
| SCHEMBL29570472 | 0.91 | TERT (0.51) | MEN1KMT2ATERTDPP7ALDH1A1 | |
| SCHEMBL29388130 | 0.90 | TERT (0.41) | MEN1KMT2ATERTDPP7ALDH1A1 | |
| SCHEMBL10789594 | 0.89 | TERT (0.40) | MEN1KMT2ATERTDPP7PRCP | |
| SCHEMBL10789606 | 0.89 | TERT (0.40) | MEN1KMT2ATERTDPP7PRCP | |
| SCHEMBL5287122 | 0.88 | TERT (0.42) | MEN1KMT2ATERTDPP7PRCP | |
| SCHEMBL12601584 | 0.88 | TERT (0.42) | MEN1KMT2ATERTDPP7PRCP | |
| SCHEMBL1369569 | 0.88 | DPP7 (0.43) | MEN1KMT2ATERTDPP7PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250123280-A1 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | UNIV OREGON HEALTH & SCIENCE (US) | 2025-04-17 | — | — | US | claimed |
| US-20240287509-A1 | NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2024-08-29 | — | — | US | claimed |
| WO-2023003984-A2 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-01-26 | — | — | WO | claimed |
| EP-4056168-A9 | NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF | Shanghai Jiaotong University School of Medicine (CN) | 2022-11-23 | — | — | EP | claimed |
| EP-4056168-A1 | NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF | Shanghai Jiaotong University School of Medicine (CN) | 2022-09-14 | — | — | EP | claimed |
| US-12618835-B2 | Multiplex microelectrode array for detection of proteases as biomarkers | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | BAYER AKTIENGESELLSCHAFT (DE) | 2025-08-26 | — | — | US | disclosed |
| US-12371691-B2 | Nano complex for targeted repairing of neurovascular lesion, and preparation and use thereof | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2025-07-29 | — | — | US | disclosed |
| CN-115720578-B | And tricyclic derivatives, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250123280-A1 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | UNIV OREGON HEALTH & SCIENCE (US) | 2025-04-17 | — | — | US | disclosed |
| US-20240287509-A1 | NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2024-08-29 | — | — | US | disclosed |
| CN-113735825-B | 1,2,3, 6-Tetrahydropyridine compound and preparation method and application thereof | 成都康弘药业集团股份有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-115720578-A | Tricyclic derivative, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2023-02-28 | — | — | CN | disclosed |
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | US | disclosed |
| US-20230027985-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | US | disclosed |
| WO-2023003984-A2 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-01-26 | — | — | WO | disclosed |
| US-20220412975-A1 | CHARACTERIZING MODULATORS OF ADAMTS-7 AND ADAMTS-12 | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-29 | — | — | US | disclosed |
| EP-4056168-A9 | NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF | Shanghai Jiaotong University School of Medicine (CN) | 2022-11-23 | — | — | EP | disclosed |
| US-20220349880-A1 | MULTIPLEX MICROELECTRODE ARRAY FOR DETECTION OF PROTEASES AS BIOMARKERS | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA | 2022-11-03 | — | — | US | disclosed |
| EP-4056168-A1 | NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF | Shanghai Jiaotong University School of Medicine (CN) | 2022-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618835-B2 | Multiplex microelectrode array for detection of proteases as biomarkers | APAF1, ADAM33, UCHL1 | MEN1 4195/4885KMT2A 3531/4885TERT 2743/4885 |
| US-20230027985-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | ADAMTS7, MMP7, ADAMTS1 | MEN1 2636/4885KMT2A 3100/4885TERT 4570/4885 |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | ADAMTS7, MMP7, ADAM17 | MEN1 2481/4885KMT2A 3535/4885TERT 4278/4885 |
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | ADAMTS7, MMP7, ADAM17 | MEN1 2481/4885KMT2A 3535/4885TERT 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.